Found: 7
Select item for more details and to access through your institution.
Impact of uptake time on image quality of [<sup>68</sup>Ga]Ga‐PSMA‐11 PET/CT.
- Published in:
- Medical Physics, 2023, v. 50, n. 12, p. 7619, doi. 10.1002/mp.16429
- By:
- Publication type:
- Article
Competition ('Steal' Phenomenon) between [ 68 Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 699, doi. 10.3390/pharmaceutics13050699
- By:
- Publication type:
- Article
Cost-effectiveness of the implementation of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging.
- Published in:
- Insights into Imaging, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13244-022-01265-w
- By:
- Publication type:
- Article
Tolerability of concurrent external beam radiotherapy and [<sup>177</sup>Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10725-5
- By:
- Publication type:
- Article
Lutetium-177-PSMA therapy for prostate cancer patients—a brief overview of the literature.
- Published in:
- Tijdschrift voor Urologie, 2020, v. 10, n. 6/7, p. 141, doi. 10.1007/s13629-020-00300-z
- By:
- Publication type:
- Article
PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature.
- Published in:
- Tijdschrift voor Urologie, 2020, v. 10, n. 6/7, p. 101, doi. 10.1007/s13629-020-00297-5
- By:
- Publication type:
- Article
Baseline Imaging Derived Predictive Factors of Response Following [ 177 Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071575
- By:
- Publication type:
- Article